Final NICE nod for Takeda’s Adcetris in Hodgkin’s lymphoma
admin 15th June 2017 Uncategorised 0Certain patients with Hodgkin’s Lymphoma living in England and Wales can now expect routine access to Takeda’s Adcetris on the NHS after NICE deemed the drug a cost-effective use of resources in some scenarios.
More: Final NICE nod for Takeda’s Adcetris in Hodgkin’s lymphoma
Source: News